---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-095934"
form_type: "8-K"
ticker: "NMTC"
cik: "0001500198"
company_name: "NEUROONE MEDICAL TECHNOLOGIES Corp"
filed_at: "2024-11-08T23:59:59+00:00"
generated_at: "2026-05-30T02:46:44.327708+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# NeuroOne terminates loan agreement with Growth Opportunity Funding effective Nov 7, 2024

## Summary
- NeuroOne and Growth Opportunity Funding, LLC mutually terminated the Loan and Security Agreement dated August 2, 2024 on November 7, 2024.
- As of termination date, the Company had no loan balance outstanding under the agreement.
- The original Loan Agreement terms were disclosed in the Company's 8-K filed August 7, 2024.

## SEC filing metadata
- accession: 0001213900-24-095934
- form_type: 8-K
- ticker: NMTC
- cik: 0001500198
- company_name: NEUROONE MEDICAL TECHNOLOGIES Corp
- filed_at: 2024-11-08T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1500198/000121390024095934/0001213900-24-095934-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1500198/000121390024095934/ea0220503-8k_neuro.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-095934
- JSON: https://secwatch.observer/filing/0001213900-24-095934.json
- Plain text: https://secwatch.observer/filing/0001213900-24-095934.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.